powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1437599248
Joel Michalski
MD, PHD
Hematology-Oncology
Omaha,
NE
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
1,391
Beneficiaries
—
Total drug cost
$3.9M
Distinct drugs
42
Brand share
25.7%
Top prescribed drugs
Anastrozole
120 claims
Acyclovir
105 claims
Dexamethasone
94 claims
Ondansetron Hcl
72 claims
Prochlorperazine Maleate
62 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,991
Unique beneficiaries
—
Total services
90,172
Distinct HCPCS
65
Medicare payment
$1.4M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 28 Hematology-Oncology providers in NE — above median (cohort median 149,484).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$3K
Payment records
30
By payment type
Consulting Fee
$3K
Food and Beverage
$626
Education
$90